TruTag Technologies
Latest round
- Series C
Last raised
- Oct 2019
Total raised
- $7.5M
Investors
- 2
About TruTag Technologies
TruTag Technologies, Inc.Founded in 2010 and headquartered in Emeryville, US, TruTag Technologies specializes in advanced authentication solutions. The company has undergone a strategic pivot to focus on embedding its invisible barcodes, known as TruTags®, in various products. As of November 2021, the company has completed a total of 5 investment deals.TruTag Technologies specializes in advanced authentication solutions designed to combat counterfeit goods across various industries. The company's core offering revolves around TruTags®, which are invisible, edible barcodes that can be embedded in pharmaceuticals, food products, and electronic components. These TruTags are constructed from a nanoporous 3D honeycomb structure, making them virtually impossible to replicate. Their technology enables real-time data capture for product authentication and patient compliance, addressing critical issues such as counterfeit medications, food fraud, and the integrity of electronic components. TruTag's solutions cater to a diverse clientele, including pharmaceutical manufacturers, food producers, and battery manufacturers, with applications in markets such as the United States, Australia, and China.TruTag Technologies generates revenue through strategic partnerships and the sale of its proprietary authentication solutions. The company collaborates with clients to integrate TruTags into their products, enabling robust traceability and verification processes. Transactions typically occur on a B2B basis, where manufacturers purchase TruTags and associated services as part of their production processes. These partnerships may involve contracts that outline pricing structures for product implementation, ongoing support, and data management services. TruTag’s flagship products, including its on-dose authentication platform, contribute to various applications in pharmaceutical and food industries, wherein customers benefit from enhanced product safety and compliance measures.69 mn to enhance its product offerings and expand into new geographic markets. The company is focused on developing new applications for its TruTags® and aims to launch these innovations by the end of 2022. Additionally, TruTag is targeting expansion into markets such as Europe and Southeast Asia to increase its global presence and accessibility. Through these initiatives, the firm aims to solidify its market position and enhance its capabilities in product authentication.
Who invested in TruTag Technologies
2 investors across 1 round
See all investors in TruTag Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Oct 17, 2019
Amount
$7.5M
Investors
Questions about TruTag Technologies
Who invested in TruTag Technologies?
TruTag Technologies has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TruTag Technologies raised?
TruTag Technologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did TruTag Technologies last raise money?
TruTag Technologies's most recent round on record is a Series C, in Oct 2019.
What does TruTag Technologies do?
TruTag Technologies is a pharmaceuticals company.
Where is TruTag Technologies headquartered?
TruTag Technologies is headquartered in Emeryville, US.
Which VCs invest in companies like TruTag Technologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at TruTag Technologies's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like TruTag Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.